|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan BA and Hughes BG: Targeted therapy
for non-small cell lung cancer: Current standards and the promise
of the future. Transl Lung Cancer Res. 4:36–54. 2015.PubMed/NCBI
|
|
4
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong K-K: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nature Rev Cancer. 14:5352014. View Article : Google Scholar
|
|
5
|
Smith S and Stillman B: Purification and
characterization of CAF-I, a human cell factor required for
chromatin assembly during DNA replication in vitro. Cell.
58:15–25. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verreault A, Kaufman PD, Kobayashi R and
Stillman B: Nucleosome assembly by a complex of CAF-1 and
acetylated histones H3/H4. Cell. 87:95–104. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaufman PD, Kobayashi R, Kessler N and
Stillman B: The p150 and p60 subunits of chromatin assembly factor
I: A molecular link between newly synthesized histones and DNA
replication. Cell. 81:1105–1114. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tayrac MD, Saikali S, Aubry M, Bellaud P,
Boniface R, Quillien V and Mosser J: Prognostic significance of
EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade
gliomas. PLoS One. 8:e733322013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tayrac MD, Aubry M, Saïkali S, Etcheverry
A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien
V, et al: A 4-Gene signature associated with clinical outcome in
high-grade gliomas. Clin Cancer Res. 17:317–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Staibano S, Mascolo M, Mancini FP,
Kisslinger A, Salvatore G, Di Benedetto M, Chieffi P, Altieri V,
Prezioso D, Ilardi G, et al: Overexpression of chromatin assembly
factor-1 (CAF-1) p60 is predictive of adverse behaviour of
prostatic cancer. Histopathology. 54:580–589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Staibano S, Mignogna C, Lo Muzio L,
Mascolo M, Salvatore G, Di Benedetto M, Califano L, Rubini C and De
Rosa G: Chromatin assembly factor-1 (CAF-1)-mediated regulation of
cell proliferation and DNA repair: A link with the biological
behaviour of squamous cell carcinoma of the tongue? Histopathology.
50:911–919. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Polo SE, Theocharis SE, Klijanienko J,
Savignoni A, Asselain B, Vielh P and Almouzni G: Chromatin assembly
factor-1, a marker of clinical value to distinguish quiescent from
proliferating cells. Cancer Res. 64:2371–2381. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Staibano S, Mascolo M, Rocco A, Lo Muzio
L, Ilardi G, Siano M, Pannone G, Vecchione ML, Nugnes L, Califano
L, et al: The proliferation marker chromatin assembly factor-1 is
of clinical value in predicting the biological behaviour of
salivary gland tumours. Oncol Rep. 25:13–22. 2011.PubMed/NCBI
|
|
15
|
Polo SE, Theocharis SE, Grandin L,
Gambotti L, Antoni G, Savignoni A, Asselain B, Patsouris E and
Almouzni G: Clinical significance and prognostic value of chromatin
assembly factor-1 overexpression in human solid tumours.
Histopathology. 57:716–724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mascolo M, Vecchione ML, Ilardi G,
Scalvenzi M, Molea G, Di Benedetto M, Nugnes L, Siano M, De Rosa G
and Staibano S: Overexpression of chromatin assembly Factor-1/p60
helps to predict the prognosis of melanoma patients. BMC Cancer.
10:632010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Naito S, von Eschenbach AC, Giavazzi R and
Fidler IJ: Growth and metastasis of tumour cells isolated from a
human renal cell carcinoma implanted into different organs of nude
mice. Cancer Res. 46:4109–4115. 1986.PubMed/NCBI
|
|
19
|
Hall PA and Levison DA: Review: Assessment
of cell proliferation in histological material. J Clin Pathol.
43:184–192. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nabatiyan A and Krude T: Silencing of
chromatin assembly factor 1 in human cells leads to cell death and
loss of chromatin assembly during DNA synthesis. Mol Cell Biol.
24:2853–2862. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gerdes J, Schwab U, Lemke H and Stein H:
Production of a mouse monoclonal antibody reactive with a human
nuclear antigen associated with cell proliferation. Int J Cancer.
31:13–20. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brown DC and Gatter KC: Monoclonal
antibody Ki-67: Its use in histopathology. Histopathology.
17:489–503. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mascolo M, Ilardi G, Merolla F, Russo D,
Vecchione ML, de Rosa G and Staibano S: Tissue microarray-Based
evaluation of chromatin assembly factor-1 (CAF-1)/p60 as tumour
prognostic marker. Int J Mol Sci. 13:11044–11062. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schaal C and Chellappan SP:
Nicotine-mediated cell proliferation and tumor progression in
smoking-related cancers. Mol Cancer Res. 12:14–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barbieri E, De Preter K, Capasso M, Chen
Z, Hsu DM, Tonini GP, Lefever S, Hicks J, Versteeg R, Pession A, et
al: Histone chaperone CHAF1A inhibits differentiation and promotes
aggressive neuroblastoma. Cancer Res. 74:765–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levine AJ, Feng Z, Mak TW, You H and Jin
S: Coordination and communication between the p53 and IGF-1-AKT-TOR
signal transduction pathways. Genes Dev. 20:267–275. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marchenko ND, Zaika A and Moll UM: Death
signal-induced localization of p53 protein to mitochondria. A
potential role in apoptotic signaling. J Biol Chem.
275:16202–16212. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuwana T, Mackey MR, Perkins G, Ellisman
MH, Latterich M, Schneiter R, Green DR and Newmeyer DD: Bid, bax,
and lipids cooperate to form supramolecular openings in the outer
mitochondrial membrane. Cell. 111:331–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leu J, Dumont P, Hafey M, Murphy ME and
George DL: Mitochondrial p53 activates Bak and causes disruption of
a Bak-Mcll complex. Nat Cell Biol. 6:443–450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tomita Y, Marchenko N, Erster S,
Nemajerova A, Dehner A, Klein C, Pan H, Kessler H, Pancoska P and
Moll UM: WT p53, but not tumor-derived mutants, bind to Bcl2 via
the DNA binding domain and induce mitochondrial permeabilization. J
Biol Chem. 281:8600–8606. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giono LE and Manfredi JJ: The p53 tumor
suppressor participates in multiple cell cycle checkpoints. J Cell
Physiol. 209:13–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nurse P: Universal control mechanism
regulating onset of M-phase. Nature. 344:503–508. 1990. View Article : Google Scholar : PubMed/NCBI
|
